Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls.

Case-control studies are commonly used to evaluate effectiveness of licensed vaccines after deployment in public health programs. Such studies can provide policy-relevant data on vaccine performance under 'real world' conditions, contributing to the evidence base to support and sustain int...

Full description

Bibliographic Details
Main Authors: Verani, J, Baqui, A, Broome, C, Cherian, T, Cohen, C, Farrar, J, Feikin, D, Groome, M, Hajjeh, R, Johnson, H, Madhi, S, Mulholland, K, O'Brien, K, Parashar, U, Patel, M, Rodrigues, L, Santosham, M, Scott, J, Smith, P, Sommerfelt, H, Tate, J, Victor, J, Whitney, C, Zaidi, A, Zell, E
Format: Journal article
Language:English
Published: Elsevier 2017
_version_ 1797103525119918080
author Verani, J
Baqui, A
Broome, C
Cherian, T
Cohen, C
Farrar, J
Feikin, D
Groome, M
Hajjeh, R
Johnson, H
Madhi, S
Mulholland, K
O'Brien, K
Parashar, U
Patel, M
Rodrigues, L
Santosham, M
Scott, J
Smith, P
Sommerfelt, H
Tate, J
Victor, J
Whitney, C
Zaidi, A
Zell, E
author_facet Verani, J
Baqui, A
Broome, C
Cherian, T
Cohen, C
Farrar, J
Feikin, D
Groome, M
Hajjeh, R
Johnson, H
Madhi, S
Mulholland, K
O'Brien, K
Parashar, U
Patel, M
Rodrigues, L
Santosham, M
Scott, J
Smith, P
Sommerfelt, H
Tate, J
Victor, J
Whitney, C
Zaidi, A
Zell, E
author_sort Verani, J
collection OXFORD
description Case-control studies are commonly used to evaluate effectiveness of licensed vaccines after deployment in public health programs. Such studies can provide policy-relevant data on vaccine performance under 'real world' conditions, contributing to the evidence base to support and sustain introduction of new vaccines. However, case-control studies do not measure the impact of vaccine introduction on disease at a population level, and are subject to bias and confounding, which may lead to inaccurate results that can misinform policy decisions. In 2012, a group of experts met to review recent experience with case-control studies evaluating the effectiveness of several vaccines; here we summarize the recommendations of that group regarding best practices for planning, design and enrollment of cases and controls. Rigorous planning and preparation should focus on understanding the study context including healthcare-seeking and vaccination practices. Case-control vaccine effectiveness studies are best carried out soon after vaccine introduction because high coverage creates strong potential for confounding. Endpoints specific to the vaccine target are preferable to non-specific clinical syndromes since the proportion of non-specific outcomes preventable through vaccination may vary over time and place, leading to potentially confusing results. Controls should be representative of the source population from which cases arise, and are generally recruited from the community or health facilities where cases are enrolled. Matching of controls to cases for potential confounding factors is commonly used, although should be reserved for a limited number of key variables believed to be linked to both vaccination and disease. Case-control vaccine effectiveness studies can provide information useful to guide policy decisions and vaccine development, however rigorous preparation and design is essential.
first_indexed 2024-03-07T06:21:18Z
format Journal article
id oxford-uuid:f2cd9fe4-b137-451d-83f4-84485ce8a644
institution University of Oxford
language English
last_indexed 2024-03-07T06:21:18Z
publishDate 2017
publisher Elsevier
record_format dspace
spelling oxford-uuid:f2cd9fe4-b137-451d-83f4-84485ce8a6442022-03-27T12:06:57ZCase-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f2cd9fe4-b137-451d-83f4-84485ce8a644EnglishSymplectic Elements at OxfordElsevier2017Verani, JBaqui, ABroome, CCherian, TCohen, CFarrar, JFeikin, DGroome, MHajjeh, RJohnson, HMadhi, SMulholland, KO'Brien, KParashar, UPatel, MRodrigues, LSantosham, MScott, JSmith, PSommerfelt, HTate, JVictor, JWhitney, CZaidi, AZell, ECase-control studies are commonly used to evaluate effectiveness of licensed vaccines after deployment in public health programs. Such studies can provide policy-relevant data on vaccine performance under 'real world' conditions, contributing to the evidence base to support and sustain introduction of new vaccines. However, case-control studies do not measure the impact of vaccine introduction on disease at a population level, and are subject to bias and confounding, which may lead to inaccurate results that can misinform policy decisions. In 2012, a group of experts met to review recent experience with case-control studies evaluating the effectiveness of several vaccines; here we summarize the recommendations of that group regarding best practices for planning, design and enrollment of cases and controls. Rigorous planning and preparation should focus on understanding the study context including healthcare-seeking and vaccination practices. Case-control vaccine effectiveness studies are best carried out soon after vaccine introduction because high coverage creates strong potential for confounding. Endpoints specific to the vaccine target are preferable to non-specific clinical syndromes since the proportion of non-specific outcomes preventable through vaccination may vary over time and place, leading to potentially confusing results. Controls should be representative of the source population from which cases arise, and are generally recruited from the community or health facilities where cases are enrolled. Matching of controls to cases for potential confounding factors is commonly used, although should be reserved for a limited number of key variables believed to be linked to both vaccination and disease. Case-control vaccine effectiveness studies can provide information useful to guide policy decisions and vaccine development, however rigorous preparation and design is essential.
spellingShingle Verani, J
Baqui, A
Broome, C
Cherian, T
Cohen, C
Farrar, J
Feikin, D
Groome, M
Hajjeh, R
Johnson, H
Madhi, S
Mulholland, K
O'Brien, K
Parashar, U
Patel, M
Rodrigues, L
Santosham, M
Scott, J
Smith, P
Sommerfelt, H
Tate, J
Victor, J
Whitney, C
Zaidi, A
Zell, E
Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls.
title Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls.
title_full Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls.
title_fullStr Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls.
title_full_unstemmed Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls.
title_short Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls.
title_sort case control vaccine effectiveness studies preparation design and enrollment of cases and controls
work_keys_str_mv AT veranij casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT baquia casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT broomec casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT cheriant casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT cohenc casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT farrarj casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT feikind casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT groomem casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT hajjehr casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT johnsonh casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT madhis casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT mulhollandk casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT obrienk casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT parasharu casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT patelm casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT rodriguesl casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT santoshamm casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT scottj casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT smithp casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT sommerfelth casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT tatej casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT victorj casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT whitneyc casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT zaidia casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols
AT zelle casecontrolvaccineeffectivenessstudiespreparationdesignandenrollmentofcasesandcontrols